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ARTICLE INFO

ABSTRACT

Discipline:

Aim: This case report aims to demonstrate among health providers the importance of timely surgical and prosthetic
management procedures of patients who suffered from the newly combined clinical entity of post COVID 19 mucormycosis
and osteomyelitis of the palate. Materials and methods: Elaborate advanced diagnosis of the patients including CBCT,
MRI, CT, Pathology examination, 3Ds printing reconstruction of the whole skull and digital design of reconstructive mesh
that support the prosthesis were carried out. The patients undergone modified infrastructure maxillectomy and immediate
prosthetic obturation of the palatal defect that was replaced later by a delayed obturator. Results: Surgical eradication of
the necrotic bone and subsequent immediate obturation of the defect minimized morbidly and helped in improving the
quality of life of these patients. Conclusion: Early diagnosis of this potentially fatal disease and reach-out a treatment plan
immediately, is of prime importance in reducing the morbidly and mortality rate and enhance speech and eating in the two
patients reported. It also decreases the psychological impact of this radical surgery.
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1.

INTRODUCTION

Coronavirus disease (COVID-19) that emerged to the surface in 2019,
caused by the novel severe acute respiratory syndrome coronavirus 2 (SARSCoV-2), is the leading cause of a global breakthrough pandemic,1,2 Beside
the Acute Respiratory Distress Syndromes (ARDS) caused by it, COVID-19
patients were found to have multiple symptoms and immune-suppression
attributed to an impaired cell mediated immune response with drop in CD4+T
and CD8+T cells.3 This resulted in a wide spectrum of bacterial and fungal
infections that may co-exist with possible association with a preexisting
morbidity (diabetes mellitus, lung disease) or may develop as a hospitalacquired infection.1–7
Acute invasive fungal rhinosinusitis (AIFR) is a time-sensitive condition
that must be recognized and treated promptly to avoid life-threatening
complications. Madeny et al reported that in a 10-year study that was carried
out in Egypt, 45 cases of proven invasive fungal sinusitis were diagnosed
which is comparable to the relative incidence present in other countries.8
El Kholy et al reported that nearly 5 to 7 invasive fungal sinusitis cases are
diagnosed per year.9–15
A combination of these factors makes the hospitalized COVID-19
patients a potential high-risk group for fungal infections like aspergillosis
and mucormycosis. Aspergillosis is linked with fungus spheres of the sinuses

without tissue invasion, mucormycosis in contrary is an angioinvasive fungal
infection, which causes ischemic necrosis of the regions involved. The
clinical progressive course is rapid with case fatality rate of 46%.15 Careful
monitoring of immunocompromised patients and COVID-19 patients,
with history of hospital admission for oxygen support is necessary, as this
category of patients frequently has comorbid conditions like diabetes, renal
failure and is usually administered steroids / antibiotics as part of COVID-19
management protocol.16 17
Maxillary osteomyelitis was considered rare due to the thinner bone and
better vascularity as compared to the mandible. Apart from the uncommonness of maxillary osteomyelitis, fungal infection of the maxillary sinuses was
also considered infrequent, seen mainly in immune-compromised patients.
With the rise in COVID-19 cases, there has been a raise in patients with fungal osteomyelitis coupled with diabetes mellitus, and affect more the maxilla.
Diabetes by itself reduces the vascularity of the bone, which, coupled with
the fungal organisms compressing the blood vessels, leads to ischemia and
necrosis.18–25 Many conditions are well known to lead to perforation of the
palate like tumors, disease, and accidents. However, Heroin abuse was also
reported to cause palatal perforation.26 The aim of this study is to demonstrate
surgical and prosthetic management of two patients who suffered from the
newly combined clinical entity of post COVID 19 mucormycosis and osteomyelitis of the palate.
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CLINICAL REPORT

This clinical report reported two patients who had post-COVID 19
mucormycosis with osteomyelitis in the maxilla requiring maxillectomy
followed by planned rehabilitation. The condition is rare but is of clinical
interest. Dentists should be aware of such oral complications after COVID 19.
Patient # 1:
A 65-year uncontrolled diabetic male patient has suffered from COVID
19 virus in January 2021 and was referred for prosthetic consultation on July
2021. Reviewing the history and the course of treatment, it was found that
patient has the COVID 19 virus and was admitted to a hospital for 4 weeks. He
was in the intensive care and on oxygen support. During his hospital stay, he
has treated with antibacterial and steroid medicines. After discharge from the
hospital, he felt an opening in his right part of the maxilla. He was readmitted
to the hospital and all investigations were carried out again. The diagnosis was
post COVID 19 mucormycosis that required surgical debridement, extraction
of all his maxillary teeth and anti-fungal drugs administration.
On a thorough intraoral examination, the patient has undergone an
extensive debridement surgery by an ENT surgeon. All his teeth were
extracted and left with palatal perforation in his right maxilla 4 cm long and
1 cm width. As radiographic examination is very important at this stage to
detect the extension of the destruction of the invasive mucormycosis in the
maxilla and the surrounding organs. A Cone Beam 3 Ds radiographs were
made to evaluate the extension of destruction in three dimensions. The
DICOM file of the patient’s whole skull was 3Ds printed to resin in order
to facilitate visualization of the defect and help communication with the
patient. The amount of destruction was huge, invaded almost completely right
palatine bone and approached the infraorbital bone Fig. (1). Insufficient bone
for implant placement was detected in both the right and left maxilla and
in the pre-maxilla. All this destruction occurred in only one-month period
post hospitalization. An alternative treatment plane that includes fabrication
of subperiosteally reconstructive mesh that is fixed with fixation screws to
the remaining bone. This mesh has implants protruding in the oral cavity
to support the prosthesis. This was achieved with the aid of special digital
software (Fig. (2). Working with three-dimensional (3D) intra-oral scanning
it was possible to combine the data of the intra-oral situation, like the position
of the ridge and remaining bone, with CBCT and magnetic resonance imaging
(MRI) data of the surrounding tissues in an augmented model. This 3D virtual
model provides more insight into the implications and complexity of surgical
and prosthetic rehabilitation. Segmentation of the DICOM file was done by
the aid of (Mimics, Materialize software) to transform the DICOM file to STL
file. The reconstruction mesh was designed by (Meshmixer software)

March 2021. Microscopic examination of the specimen revealed ulcerated
markedly inflamed respiratory mucosal fragments mixed with fungal hyphae
and spores predominantly Macour species. Dense diffuse mixed inflammatory
cellular infiltrate was seen that included acute and chronic inflammatory
cells predominated by plasma cells associated with few multinucleated
inflammatory giant cells, fibrotic bands were also seen. The fibro-inflammatory
reaction presented the included necrotic bony trabeculae. The diagnosis was
right ethmoid lesions FESS: Invasive deep fungal sinusitis (mucormycosis)
with osteomyelitis. The CT and MRI reports confirmed the pathology results
and indicated that current findings are suggestive of osteomyelitis of the bony
boundaries of right sided PNS together with intracranial enhancing lesions.
The CT report considered this lesion is a sequel of invasive fungal sinusitis.

Figure (1) — STL files that were converted from the DICOM files of the patient’s
skull and were 3Ds printed into resin to demonstrate the huge destruction in
right and left sides of the maxilla.

Hoverer, after seven months from the beginning of the COVID 19,
and during finalization of the rehabilitation treatment plan, the patient got
a cerebral stroke that affected his left arm and leg and impaired his ability
to walk without support. After consultation with medical and dental teams
and assessment of the investigations and the general health of the patient,
the decision was to abort this treatment plan and avoid any further surgical
intervention and go only for removable obturator prosthesis to close the defect.
The patient was reluctant to accept this line of treatment as he had hoped
to have implant-supported fixed prosthesis instead, which was completely
contra indicated at this stage.
Patient #2:
A 55-year male patient was referred for prosthetic consultation. The
history of the patient and investigation findings were consistent with a
diagnosis of COVID-19 at the beginning of January 2021. During his hospital
stay, he has treated with antibacterial and steroid medicines. By the end of
February 2021, the patient developed an opening in the palate. An ENT
surgeon subsequently did debridement of the right sinus and extracted his
right maxillary teeth. The debris was sent for a pathology examination on
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Figure (2) — Digitally designed reconstructive mesh with its fixation screws and
its protruding implants.

At that stage, the patient was referred to the prosthodontist who
requested a CBCT image. CBCT scan was taken with Field of view 10 × 10
and reconstructions were made in axial, coronal, and sagittal planes. CBCT
report on October 2021 revealed that the findings were indicative of invasive
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destruction of the right maxillary alveolus extending from tooth 23 to tooth
28, secondary to a lesion originating from the maxillary sinus. Integrating
the findings of the CBCT scan and the pathology reports, a final diagnosis
of mucormycosis with osteomyelitis of the right maxilla secondary to fungal
infection was reached. His glycated hemoglobin (HbA1c) was 7% in the
beginning; therefore, blood sugar levels were controlled with subcutaneous
insulin during the hospital stay. He recovered satisfactorily and was released
from the hospital on antifungal medicine (traconazole - Sporanox). Fig. (3-6)

49

(sequestration separation) was observed, on palpation, a bone area of about
5.5 X 2.5 cm has a slight mobility.
A treatment plan that included surgical removal of sequestration and
remnants of the right maxilla, and obturation the defect with immediate
obturator prosthesis was initiated.

Figure (3) — CBCT images showing the extent of destruction in the right maxilla
Figure (6) — DICOM images after converted to STL showing the destruction in
the right maxilla: (a): side view (b); from the base of the skull

The planned surgery with the amount of excision expected was studied
with the surgical team. The team expected that the resection would result in a
defect matching to Aramany’s Class I. Maxillary and mandibular irreversible
hydrocolloid impressions (Zelgan, Dentsply) were made with stock trays. The
casts were poured in type III gypsum and the expected line of resection was
marked on the cast, which was altered to conform to the proposed surgical
resection. Immediate surgical obturator prosthesis was fabricated of heat cure
acrylic resin. It was retained using multiple wrought wire clasps Fig. (7).
Insertion of the immediate surgical obturator was carried out immediately in
the operating room after the surgical resection was completed. The borders
of the obturator were adjusted to ensure a passive fit and not to cause any
irritation to the reconstructed flap.
Figure (4) — Pre-operative intraoral view of the palate showing the sequestrum
and the opening of the right maxilla

Figure (5) — Cone beam computed tomography scan in (a) Axial section-mixed
density lesion showing the sequestrum and the opening of the right maxilla (b)
Coronal section-unilateral breach of maxillary sinus and floor of the nose with
blocked sinus ostium

On intra oral examination, the alveolar process of the upper jaw on
the right side, the gingiva is absent, alveolar bone is bared, bone color is
yellowish-cyanotic, during this period all right maxillary teeth are missing,
the gum mucosa is not red, no swelling, mucosa does not show signs of
acute inflammation. Pathological displacement of the bone of the hard palate
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Figure (7) —Pre-planning of the surgery and immediate obturator extension on
the cast
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Surgical procedures:
The patient was admitted to a hospital, prepared for a modified
infrastructure maxillectomy that include removal the hard palate (roof of the
mouth), lower part of the maxilla, and teeth in the right maxilla. It does not
necessitate the removal of the orbital floor (bone below eye). An incision
lateral to the nose then curving around ala to reach the lateral philtrum column
was done. Cutting through the whole thickness of the lip then sub periosteal
dissection was carried out protecting the mucosa overlying the maxilla to use
it as a lining of the reflected flap. Osteotomies were done anteriorly at the
alveolar margin between two central incisors then the anterior wall of the
maxilla at the zygomatic-maxillary junction by osteotome and mallet. The
resected segment was pushed down to expose the infratemporal fossa where
structures were clamped and cut to free the resected maxilla. Hemostasis
was completed then a pack was applied to fill the cavity. This is followed by
applying the temporary immediate prosthesis and the wound was closed in
layers using 3/0 vicryl sutures by an experienced plastic surgeon. Fig. (8-10).

Figure (9) — The fitting surface of the delayed obturator

Prosthetic procedures:
Two weeks after the surgery, a delayed hollowed obturator replaced the
immediate obturator. After removal of the surgical packing, and the sutures.
Minimal scar was noticed. Major medial undercut was blocked-out with
Vaseline gauze before making the impression. A stock tray was modified by
adding putty rubber base on the fitting surface of the right side to fill partly
the defect space (to be away from incompletely healed tissue). Irreversible
hydrocolloid was loaded in the modified stock tray and used to make the
final impression. The tray with the hydrocolloid was positioned and the
impression was made. The prosthesis was fabricated from acrylic resin,
hollowed, adjusted and delivered to the patient. During the denture insertion
appointment, the patient’s occlusion, phonetics, and esthetics were checked,
and the patient was asked to drink water to check for nasal regurgitation of
fluids.
This new design of hollow obturator has certain advantages like light
in weight, enhancement in retention with restoring form and function for
the patient over the conventional obturator design. The patient experienced
immediate improvement in speech and reproduction of palatal contour that
allowed easier swallowing of food. It also, preserved the contour of the check.

Figure (10) —The delayed obturator in place after two weeks from the surgery.
The flap sutures were almost concealed.

3.

DISCUSSION

Fungal osteomyelitis is a rare entity in the maxillofacial region. However,
the COVID-19 pandemic has caused a rise in the number of cases with postcovid fungal osteomyelitis of jaws. Mucormycosis that is associated with osteomyelitis is a possibly fatal infection that is found mostly in immune-compromised patients and considered the most harmful subtype of fungal sinusitis
with subsequent serious morbidity and mortality. The most often affected individuals with invasive fungal infections include those with malignancy, uncontrolled diabetes, AIDS, immunosuppressive, and chemotherapeutic drugs
and recently, COVID.4,5 Literature review regarding association of AIFR with
COVID-19 revealed only sparse case reports.6,7
Figure (8) — Immediate obturator in place after closure of the flap in the
operating room.
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Reports indicated that patients who were hospitalized in intensive care
units for COVID-19 has risk for invasive fungal infections particularly
in individuals having chronic respiratory diseases, corticosteroid therapy.
In recent studies observed that, in COVID-19 infected patient who treated
with widespread use of broad-spectrum antibiotic or steroid and recovered
developed secondary bacterial or fungal infection in 8% of patients.25 Auluck
reported a case of Maxillary necrosis by mucormycosis,27 and indicated that
tissue necrosis; a character of mucormycosis is often a late sign. Mehta et
al reported two cases having clinical features, which pointed towards fungal
maxillary osteomyelitis.7 Mucormycosis cases have been reported in India
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as well as in many other countries like Brazil, Chile, Honduras, Mexico,
Paraguay, the United States, Uruguay, Italy, and the United Kingdom.28
In a recent report by WHO indicated that globally, the highest number of
cases has been reported in India, where it is estimated that there are more
than 4,000 people with COVID-19 associated Mucormycosis (CAM). In a
retrospective multicenter study conducted in India between September to
December 2020, it was found that among 287 patients with mucormycosis,
187 (65.2%) had CAM; with a prevalence of 0.27% among hospitalized
patients with COVID-19. When comparing the period under study
with the same period in 2019, a 2.1-fold increase in mucormycosis was
observed. Regarding the characteristics of the 187 patients with CAM,
80.2% were male, 32.6% had COVID-19 as the only underlying disease,
78.7% were treated with gluco-corticosteroids for COVID-19, 60.4% had
diabetes mellitus, 62.6% had rhino-orbital mucormycosis, and 23.5% had
rhino-orbital-cerebral mucormycosis 28.
Mucormycosis in the bone marrow may promote fungal growth by
ruining the endothelial lining of vessels, resulting in vascular inadequacy
and leading to bony necrosis and fungal osteomyelitis. This complication is
more harmful than the more common bacteria-associated osteomyelitis.28 The
fatality rate of mucormycosis is 46% globally.15
The Steroids are also used to reduce inflammation in the lungs in Covid-19
cases and reported that it minimizes the end organ damage. However, they
also reduce immunity and raise up blood sugar levels in both diabetics and
non-diabetic COVID 19 patients. This reduction in immunity can lead to
mucormycosis.29 A recent report suggested also, that melatonin deficiency is a
key factor that increases the susceptibility of the patients to mucormycosis.30
In this clinical report, two post- COVID 19 mucormycosis patients were
referred for prosthetic obturation. Both patients have mucormycosis that
evoked after infection with COVID 19 and subsequent hospitalization and
being in intensive care units. Both patients share almost the same history and
manifestations. Their history includes uncontrolled diabetes during their first
stay at the hospital and treatment with antibiotics and steroids. Also, includes
presence of tissue invasion by fungal elements over very short clinical
course of less than 4 weeks. One of them developed osteomyelitis with
mucormycosis that invaded his right maxilla and turned the bone in this area
into necrotic sequestrated boney remnants. Despite his severely debilitated
conditions, compromised general health, suffered from stroke, which is a
major complication of mucormycosis,28 and low volume of bone in both sides
that negate the use of implants, the first patient refused to have removable
non-invasive obturator. He was lost to follow-up and did not complete the
proposed treatment plan.
However, in the second patient, an extensive surgery to remove the
necrotic sequestrum and immediate obturator prosthesis to close the defect
were carried out promptly. The outcome of this treatment plan resulted in
complete eradication of the necrotic bone and tissue and stopped progression
of the disease to the neighboring organs. The timing of the intervention and
surgical procedures is very crucial; it is well documented now that the prompt
identification and management of these lesions would significantly reduce
morbidity and mortality.29–35
This patient received an immediate obturator the day of the surgery and
then a delayed obturator replaced it (by partly filing the defect cavity) after
two weeks. The immediate obturator provided a surgical matrix on which
the surgical packing was placed. It also, enabled the patient to speak and eat
more effectively postoperatively without nasal regurgitation. The surgical
sutures were concealed around the ala of the nose and showed satisfactory
cosmetic results. This obturator lessens also, the psychologic impact of this
extensive surgery and made it easier to bear. The obturator prosthesis restored
the patient’s self-image of his appearance by reproducing the contour of the
lost oral structures that support the cheeks and allowed the patient to function
socially and normally. In some cases, prosthetic retentive considerations are
critical to achieve successful prosthetic rehabilitation. The obturator was
made hollow to be light in weight and help in enhancing the retention of the
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prosthesis. The size of the defect and number of critical remaining teeth that
may serve as anchorage for conventional clasp supported removable partial
denture framework add challenges to the maxillofacial prosthodontists.
Thus, a prosthodontist plays a vital role in the rehabilitation of total/subtotal
maxillectomy patients by separating the oral and the nasal cavities, restoring
the normal speech and mastication, along with improved aesthetics. In
the presented case, the emphasis was more on the intaglio surface and
occlusion with reduced cusp angles for better retention and stability of the
prosthesis functionally. Though an acrylic prosthesis was fabricated, metal
could have been a better option; however, owing to the cost factor and
the increase in the number of visits, acrylic was preferred. An implantsupported prosthesis was a viable treatment option for better retention, but
conventional obturators were preferred to avoid further surgical intervention.
Several studies have reported the successful rehabilitation of maxillectomy
patients with conventional obturators. The major role of a prosthodontist in
treating maxillectomy patients does not end by rehabilitation of the lost oral
function and aesthetics but also by rehabilitating and restoring the patient’s
mental health 38.
4.

CLINICAL IMPLICATIONS

Proper strict recommendations are essential to limit the intake of
drugs related to reduced immunity in the COVID-19 patients, survivors
and COVID-19 people with additional illness like diabetes, inflammatory
disorders and those undergoing chemotherapies or other treatments to
recognize the mycoses in its initial stages to increase their livelihood.36
According to The US Centre for Diseases Control and Prevention (CDC),
an overall all-cause mortality rate of 54% was reported for Mucormycosis. The
mortality rate depends upon the underlying condition of the patient, fungus
type, and affected site in the body (for example, the mortality rate reported
was 46% for patients with sinus infections, 76% for pulmonary infections,
and 96% for disseminated mucormycosis) (CDC, 2021). The difficulty and
delay in diagnosing Mucormycosis affects the outcome of the disease and may
lead to poor prognosis because of its high invasiveness and its intrinsic low
susceptibility to antifungal agents. Therefore, early diagnosis and treatment
are necessary.37According to recent WHO report, prevention of COVIDassociated mucromycosis needs to focus on addressing the underlying risk
factors such as better glycemic control in those with diabetes, appropriate use
of systemic corticosteroids and prevention of unnecessary use of antibiotic,
antifungal and other immunomodulators.28,38 Dentists also, have an important
role and should be aware of the increased incidence of mucormycosis in
Post COVID patients, especially in poorly controlled diabetes and other
immunocompromised individuals. The role of dentist and prosthodontist in
identifying the disease and its management is essential. Symptoms such as
atypical facial or sinus pain, blackish discharge, unexpected toothache, bare
bone and perforation of the palate should make the dental practitioners alert
and ready to manage.
5.

CONCLUSION

There are a rising numbers of COVID-19 recovered patients who are
presenting with an increasing number of fungal osteomyelitis of the jaws.
A multidisciplinary team approach is crucial for the early diagnosis and
management of Mucormycosis, such a devastated disease. The proper
diagnosis with all the available advanced investigations, pathology and
3 Ds radiographs and models are the keys for proper management of this
aggressive disease. The timing of the intervention has a significant impact
on reducing morbidly and mortality. Combining surgical eradication and
prosthetic obturation could help stopping progress of the mucormycosis
and osteomyelitis. The obturator prosthesis delivered to this patient reduced
the morbidity that may occur because of this extensive surgery and helped
enhancement of the patient’s quality of life.
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